NYSEAMERICAN : ATNM
Actinium Pharmaceuticals, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1.4918 USD (Oct 30, 2026, 1:05 PM EDT) · Market cap 46.90M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Actinium Pharmaceuticals, Inc. (ATNM) reported revenue of 35.09M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Other Revenue | 35.09M | 90.00K | 81.00K | 1.03M | 1.14M | |
| Revenue | 35.09M | 90.00K | 81.00K | 1.03M | 1.14M | |
| Gross Profit | 35.09M | 90.00K | 81.00K | 1.03M | 1.14M | |
| Selling, General & Admin | 7.41M | 15.21M | 12.08M | 13.33M | 12.00M | 8.08M |
| Research & Development | 18.12M | 21.12M | 30.05M | 38.67M | 23.14M | 18.03M |
| Operating Expenses | 25.53M | 36.34M | 42.12M | 52.00M | 35.13M | 26.11M |
| Operating Income | 9.56M | -36.25M | -42.12M | -51.92M | -34.10M | -24.96M |
| Interest & Investment Income | 1.75M | 2.36M | 3.88M | 3.10M | 1.09M | 190.00K |
| Pretax Income | 11.31M | -33.89M | -38.24M | -48.82M | -33.02M | -24.77M |
| Net Income | 11.31M | -33.89M | -38.24M | -48.82M | -33.02M | -24.77M |
| Net Income to Common | 11.31M | -33.89M | -38.24M | -48.82M | -33.02M | -24.77M |
| Shares Outstanding (Basic) | 31.26M | 31.20M | 30.07M | 26.60M | 24.14M | 20.57M |
| Shares Outstanding (Diluted) | 31.26M | 31.20M | 30.07M | 26.60M | 24.14M | 20.57M |
| EPS (Basic) | 0.36 | -1.09 | -1.27 | -1.83 | -1.37 | -1.20 |
| EPS (Diluted) | 0.36 | -1.09 | -1.27 | -1.83 | -1.37 | -1.20 |
| Free Cash Flow | -23.25M | -24.68M | -33.08M | -47.49M | 8.28M | -21.00M |
| Free Cash Flow Per Share | -0.74 | -0.79 | -1.10 | -1.78 | 0.34 | -1.02 |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | |
| Operating Margin | 27.23% | -40,274.44% | -64,098.76% | -3,311.07% | -2,182.17% | |
| Profit Margin | 32.23% | -37,652.22% | -60,269.14% | -3,205.53% | -2,165.56% | |
| Free Cash Flow Margin | -66.25% | -27,426.67% | -58,627.16% | 803.69% | -1,835.58% | |
| EBITDA | 9.79M | -36.06M | -41.91M | -51.71M | -33.90M | -24.78M |
| D&A For EBITDA | 235.00K | 183.00K | 207.00K | 210.00K | 207.00K | 186.00K |
| EBIT | 9.56M | -36.25M | -42.12M | -51.92M | -34.10M | -24.96M |
| Revenue as Reported | 35.09M | 90.00K | 81.00K | 1.03M | 1.14M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 36.47M | 48.00M | 72.90M | 76.68M | 108.91M | 77.83M |
| Cash & Short-Term Investments | 36.47M | 48.00M | 72.90M | 76.68M | 108.91M | 77.83M |
| Prepaid Expenses | 1.27M | 1.38M | 1.60M | 1.59M | 1.64M | 1.48M |
| Restricted Cash | 396.00K | 392.00K | ||||
| Other Current Assets | 50.00K | |||||
| Total Current Assets | 37.74M | 49.38M | 74.51M | 78.26M | 110.94M | 79.75M |
| Property, Plant & Equipment | 2.08M | 2.06M | 2.07M | 2.87M | 2.95M | 639.00K |
| Other Long-Term Assets | 339.00K | 335.00K | 324.00K | 313.00K | 302.00K | |
| Total Assets | 40.16M | 51.77M | 76.90M | 81.44M | 114.19M | 80.39M |
| Accounts Payable | 8.51M | 7.25M | 7.57M | 7.95M | 10.13M | 5.54M |
| Current Portion of Leases | 746.00K | 722.00K | 580.00K | 541.00K | 498.00K | 307.00K |
| Current Unearned Revenue | 998.00K | |||||
| Total Current Liabilities | 9.26M | 7.97M | 8.15M | 8.49M | 10.63M | 6.84M |
| Long-Term Leases | 595.00K | 972.00K | 993.00K | 1.57M | 2.08M | 3.00K |
| Long-Term Unearned Revenue | 35.00M | 35.00M | 35.00M | 35.00M | ||
| Total Liabilities | 9.86M | 43.94M | 44.14M | 45.07M | 47.71M | 6.84M |
| Common Stock | 31.00K | 31.00K | 31.00K | 28.00K | 26.00K | 22.00K |
| Additional Paid-In Capital | 417.67M | 417.54M | 408.55M | 373.93M | 355.22M | 329.27M |
| Retained Earnings | -387.33M | -409.71M | -375.83M | -337.58M | -288.76M | -255.75M |
| Comprehensive Income & Other | -60.00K | -20.00K | ||||
| Shareholders' Equity | 30.30M | 7.83M | 32.76M | 36.38M | 66.48M | 73.55M |
| Total Liabilities & Equity | 40.16M | 51.77M | 76.90M | 81.44M | 114.19M | 80.39M |
| Total Debt | 1.34M | 1.69M | 1.57M | 2.11M | 2.58M | 310.00K |
| Net Cash (Debt) | 35.13M | 46.30M | 71.33M | 74.56M | 106.33M | 77.52M |
| Net Cash Per Share | 1.12 | 1.48 | 2.37 | 2.80 | 4.40 | 3.77 |
| Filing Date Shares Outstanding | 31.44M | 31.18M | 31.20M | 29.40M | 25.73M | 22.14M |
| Total Common Shares Outstanding | 31.44M | 31.20M | 31.20M | 27.63M | 25.67M | 22.14M |
| Working Capital | 28.48M | 41.41M | 66.36M | 69.77M | 100.31M | 72.91M |
| Book Value Per Share | 0.96 | 0.25 | 1.05 | 1.32 | 2.59 | 3.32 |
| Tangible Book Value | 30.30M | 7.83M | 32.76M | 36.38M | 66.48M | 73.55M |
| Tangible Book Value Per Share | 0.96 | 0.25 | 1.05 | 1.32 | 2.59 | 3.32 |
| Machinery | 1.25M | 1.25M | 1.24M | 1.09M | 675.00K | |
| Construction In Progress | 104.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 11.31M | -33.89M | -38.24M | -48.82M | -33.02M | -24.77M |
| Depreciation & Amortization | 873.00K | 821.00K | 811.00K | 790.00K | 699.00K | 524.00K |
| Stock-Based Compensation | 248.00K | 9.19M | 5.29M | 3.84M | 2.79M | 1.69M |
| Other Operating Activities | -35.00M | |||||
| Change in Accounts Payable | 721.00K | -346.00K | -387.00K | -2.18M | 4.59M | 1.20M |
| Change in Unearned Revenue | 34.00M | 998.00K | ||||
| Change in Other Net Operating Assets | -813.00K | -358.00K | -545.00K | -972.00K | -430.00K | -503.00K |
| Operating Cash Flow | -22.66M | -24.58M | -33.07M | -47.34M | 8.64M | -20.87M |
| Capital Expenditures | -584.00K | -104.00K | -11.00K | -153.00K | -366.00K | -133.00K |
| Investing Cash Flow | -584.00K | -104.00K | -11.00K | -153.00K | -366.00K | -133.00K |
| Long-Term Debt Repaid | -10.00K | -9.00K | -4.00K | -49.00K | -85.00K | |
| Total Debt Repaid | -10.00K | -10.00K | -9.00K | -4.00K | -49.00K | -85.00K |
| Net Debt Issued (Repaid) | -10.00K | -10.00K | -9.00K | -4.00K | -49.00K | -85.00K |
| Issuance of Common Stock | 29.33M | 14.87M | 23.16M | 35.31M | ||
| Repurchase of Common Stock | -207.00K | -207.00K | ||||
| Financing Cash Flow | -217.00K | -217.00K | 29.32M | 14.87M | 23.11M | 35.22M |
| Foreign Exchange Rate Adjustments | 19.00K | 6.00K | ||||
| Net Cash Flow | -23.45M | -24.89M | -3.76M | -32.62M | 31.39M | 14.22M |
| Free Cash Flow | -23.25M | -24.68M | -33.08M | -47.49M | 8.28M | -21.00M |
| Free Cash Flow Margin | -66.25% | -27,426.67% | -58,627.16% | 803.69% | -1,835.58% | |
| Free Cash Flow Per Share | -0.74 | -0.79 | -1.10 | -1.78 | 0.34 | -1.02 |
| Levered Free Cash Flow | 7.14M | -12.85M | -20.63M | -29.70M | -14.70M | -11.88M |
| Unlevered Free Cash Flow | 7.14M | -12.85M | -20.63M | -29.70M | -14.70M | -11.88M |
| Change in Working Capital | -92.00K | -704.00K | -932.00K | -3.15M | 38.17M | 1.69M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 46.53M | 42.43M | 39.31M | 139.26M | 271.40M | 132.41M |
| Enterprise Value | 11.40M | -9.82M | -37.64M | 58.49M | 162.18M | 50.79M |
| Last Close Price | 1.48 | 1.36 | 1.26 | 5.08 | 10.65 | 6.01 |
| PS Ratio | 1.33 | 471.40 | 1,719.26 | 263.49 | 115.74 | |
| PB Ratio | 1.54 | 5.42 | 1.20 | 3.83 | 4.08 | 1.80 |
| P/TBV Ratio | 1.54 | 5.42 | 1.20 | 3.83 | 4.08 | 1.80 |
| P/FCF Ratio | 32.78 | |||||
| P/OCF Ratio | 31.40 | |||||
| EV/Sales Ratio | 0.32 | 722.14 | 157.46 | 44.40 | ||
| EV/FCF Ratio | 19.59 | |||||
| Debt / Equity Ratio | 0.04 | 0.22 | 0.05 | 0.06 | 0.04 | 0.00 |
| Debt / FCF Ratio | 0.31 | |||||
| Net Debt / Equity Ratio | -1.16 | -5.91 | -2.18 | -2.05 | -1.60 | -1.05 |
| Net Debt / EBITDA Ratio | -3.59 | 1.28 | 1.70 | 1.44 | 3.14 | 3.13 |
| Net Debt / FCF Ratio | 1.51 | 1.88 | 2.16 | 1.57 | -12.85 | 3.69 |
| Asset Turnover | 0.68 | 0.00 | 0.00 | 0.01 | 0.02 | |
| Quick Ratio | 3.94 | 6.02 | 8.95 | 9.03 | 10.25 | 11.38 |
| Current Ratio | 4.08 | 6.20 | 9.14 | 9.21 | 10.44 | 11.66 |
| Return on Equity (ROE) | 45.86% | -166.96% | -110.63% | -94.92% | -47.16% | -36.74% |
| Return on Assets (ROA) | 11.58% | -35.21% | -33.25% | -33.17% | -21.91% | -21.26% |
| Return on Capital Employed (ROCE) | 30.90% | -82.70% | -61.30% | -71.20% | -32.90% | -33.90% |
| Earnings Yield | 24.05% | -79.87% | -97.29% | -35.05% | -12.17% | -18.71% |
| FCF Yield | -49.96% | -58.18% | -84.17% | -34.10% | 3.05% | -15.86% |
| Buyback Yield / Dilution | -0.28% | -3.74% | -13.03% | -10.20% | -17.37% | -69.51% |